Madrigal Mental Care
Nano particles psychedelics in intranasal delivery for mental health conditions
Company Overview
Snapshot
Founded in September 2021 by David Gabay, Madrigal Mental Care operates with 1–10 employees. The company is currently in the Pre-Funding stage and holds one patent. In March 2024, Madrigal announced groundbreaking ketamine research for PTSD treatment and upcoming in-human clinical trials.
Business overview
Madrigal Mental Care is a Health Tech & Life Sciences company focused on developing nanotechnology-based solutions for mental health conditions. The company's core product, Nanovo, is an intranasal spray designed to deliver nanoencapsulated psychedelic substances like psilocybin, ketamine, and MDMA directly to the brain. This technology aims to provide rapid, safe, and efficient uptake for transformative treatment of conditions such as post-traumatic stress disorder (PTSD), operating within the pharmaceutical and biotechnology sectors.
Strategic signal
In March 2024, Madrigal Mental Care announced significant advancements in its ketamine research for PTSD treatment, coupled with plans for upcoming in-human clinical trials. This development signals a critical step forward in validating the company's nanotechnology-driven drug delivery platform and its potential to address severe mental health challenges, indicating a strong move towards clinical application and market readiness.
Company Intelligence Q&A
- What is Madrigal Mental Care's primary focus?
- Madrigal Mental Care is focused on using nanotechnology to accurately deliver psychedelic drugs for the treatment of mental health conditions such as post-traumatic stress disorder (PTSD).
- What is the company's flagship product?
- The company's flagship product is the Nanovo intranasal spray, designed to deliver active, nanoencapsulated psychedelic substances directly to the brain for rapid, safe, and efficient uptake.
- What was a significant development for Madrigal Mental Care in March 2024?
- In March 2024, Madrigal Mental Care announced groundbreaking ketamine research for PTSD treatment and upcoming in-human clinical trials.
- Which psychedelic drugs does Madrigal Mental Care utilize in its treatments?
- Madrigal Mental Care utilizes molecules composed of psychedelic drugs such as psilocybin, ketamine, mescaline, and MDMA.
- When was Madrigal Mental Care founded?
- Madrigal Mental Care was founded in September 2021.